MK2 and MK3 - A pair of isoenzymes?

Frontiers in Bioscience

Volumn 13, Issue 14, 2008, Pages 5511-5521

  Ronkina, Natalia ^a   Kotlyarov, Alexey ^a   Gaestel, Matthias ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokine production; Inflammation; MAPK; MAPKAP; MK; P38; Phosphorylation; Protein Kinases; Review

Indexed keywords

AVES; MAMMALIA; MUS;

ISOENZYME; MAP KINASE ACTIVATED KINASE 2; MAP-KINASE-ACTIVATED KINASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ANIMAL; GENETICS; HUMAN; KINETICS; METABOLISM; MOUSE; REVIEW;

ANIMALS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; KINETICS; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER;

EID: 52049118753     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3095     Document Type: Article

References (95)

1. Kim, Y. J., J. Shuman, M. Sette & A. Przybyla: Phosphorylation pattern of a 25 Kdalton stress protein from rat myoblasts. Biochem Biophys Res Commun, 117, 682-7 (1983) (Pubitemid 14185028)
2. Welch, W. J.: Phorbol ester, calcium ionophore, or serum added to quiescent rat embryo fibroblast cells all result in the elevated phosphorylation of two 28, 000-dalton mammalian stress proteins. J Biol Chem, 260, 3058-62 (1985) (Pubitemid 15139344)
3. Gaestel, M., W. Schroder, R. Benndorf, C. Lippmann, K. Buchner, F. Hucho, V. A. Erdmann & H. Bielka: Identification of the phosphorylation sites of the murine small heat shock protein hsp25. J Biol Chem, 266, 14721-4. (1991) (Pubitemid 21907563)
4. Benndorf, R., K. Hayess, J. Stahl & H. Bielka: Cell-free phosphorylation of the murine small heat-shock protein hsp25 by an endogenous kinase from Ehrlich ascites tumor cells. Biochim Biophys Acta, 1136, 203-7 (1992)
5. Zhou, M., H. Lambert & J. Landry: Transient activation of a distinct serine protein kinase is responsible for 27-kDa heat shock protein phosphorylation in mitogen-stimulated and heat-shocked cells. J Biol Chem, 268, 35-43 (1993) (Pubitemid 23021282)
6. Gaestel, M., B. Gross, R. Benndorf, M. Strauss, W. H. Schunk, R. Kraft, A. Otto, H. Bohm, J. Stahl, H. Drabsch & et al.: Molecular cloning, sequencing and expression in Escherichia coli of the 25-kDa growth-related protein of Ehrlich ascites tumor and its homology to mammalian stress proteins. Eur J Biochem, 179, 209-13. (1989) (Pubitemid 19097678)
7. Stokoe, D., D. G. Campbell, S. Nakielny, H. Hidaka, S. J. Leevers, C. Marshall & P. Cohen: MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. Embo J, 11, 3985-94. (1992)
8. Stokoe, D., K. Engel, D. G. Campbell, P. Cohen & M. Gaestel: Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett, 313, 307-13. (1992)
9. Engel, K., K. Plath & M. Gaestel: The MAP kinaseactivated protein kinase 2 contains a proline-rich SH3-binding domain. FEBS Lett, 336, 143-7. (1993) (Pubitemid 23362022)
10. Stokoe, D., B. Caudwell, P. T. Cohen & P. Cohen: The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem J, 296, 843-9. (1993) (Pubitemid 24008205)
11. Freshney, N. W., L. Rawlinson, F. Guesdon, E. Jones, S. Cowley, J. Hsuan & J. Saklatvala: Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell, 78, 1039-49. (1994) (Pubitemid 24292331)
12. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt & A. R. Nebreda: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell, 78, 1027-37. (1994) (Pubitemid 24292330)
13. Han, J., J. D. Lee, L. Bibbs & R. J. Ulevitch: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science, 265, 808-11. (1994) (Pubitemid 24266145)
14. McLaughlin, M. M., S. Kumar, P. C. McDonnell, S. Van Horn, J. C. Lee, G. P. Livi & P. R. Young: Identification of mitogen-activated protein (MAP) kinaseactivated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem, 271, 8488-92. (1996) (Pubitemid 26108688)
15. Sithanandam, G., F. Latif, F. M. Duh, R. Bernal, U. Smola, H. Li, I. Kuzmin, V. Wixler, L. Geil & S. Shrestha: 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region. Mol Cell Biol, 16, 868-76. (1996) (Pubitemid 26061656)
16. New, L., Y. Jiang, M. Zhao, K. Liu, W. Zhu, L. J. Flood, Y. Kato, G. C. Parry & J. Han: PRAK, a novel protein kinase regulated by the p38 MAP kinase. Embo J, 17, 3372-84. (1998) (Pubitemid 28279511)
17. Ni, H., X. S. Wang, K. Diener & Z. Yao: MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellularregulated kinase (ERK) and p38 kinase. Biochem Biophys Res Commun, 243, 492-6. (1998) (Pubitemid 28414052)
18. Shi, Y., A. Kotlyarov, K. Laaß, A. D. Gruber, E. Butt, K. Marcus, H. E. Meyer, A. Friedrich, H. D. Volk & M. Gaestel: Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination. Mol Cell Biol, 23, 7732-41. (2003) (Pubitemid 37271471)
19. Schumacher, S., K. Laass, S. Kant, Y. Shi, A. Visel, A. D. Gruber, A. Kotlyarov & M. Gaestel: Scaffolding by ERK3 regulates MK5 in development. Embo J, 23, 4770-4779. Epub 2004 Nov 11. (2004)
20. Seternes, O. M., T. Mikalsen, B. Johansen, E. Michaelsen, C. G. Armstrong, N. A. Morrice, B. Turgeon, S. Meloche, U. Moens & S. M. Keyse: Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. Embo J, 23, 4780-91. Epub 2004 Dec 2. (2004)
21. Komatsu, S., N. Murai, G. Totsukawa, M. Abe, K. Akasaka, H. Shimada & H. Hosoya: Identification of MAPKAPK homolog (MAPKAPK-4) as a myosin II regulatory light-chain kinase in sea urchin egg extracts. Arch Biochem Biophys, 343, 55-62. (1997) (Pubitemid 27274342)
22. Gaestel, M.: MAPKAP kinases-MKs-two's company, three's a crowd. Nat Rev Mol Cell Biol., 7, 120-30. (2006) (Pubitemid 43278295)
23. Ronkina, N., A. Kotlyarov, O. Dittrich-Breiholz, M. Kracht, E. Hitti, K. Milarski, R. Askew, S. Marusic, L. L. Lin, M. Gaestel & J. B. Telliez: The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol, 27, 170-81 (2007) (Pubitemid 46013242)
24. Cano, E., Y. N. Doza, R. Ben-Levy, P. Cohen & L. C. Mahadevan: Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene, 12, 805-12. (1996) (Pubitemid 26072267)
25. Chevalier, D. & B. G. Allen: Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry, 39, 6145-56. (2000) (Pubitemid 30327090)
26. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H. D. Volk & M. Gaestel: MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol, 1, 94-7. (1999) (Pubitemid 129501950)
27. Zu, Y. L., F. Wu, A. Gilchrist, Y. Ai, M. E. Labadia & C. K. Huang: The primary structure of a human MAP kinase activated protein kinase 2. Biochem Biophys Res Commun, 200, 1118-24. (1994) (Pubitemid 24146078)
28. Plath, K., K. Engel, G. Schwedersky & M. Gaestel: Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro. Biochem Biophys Res Commun, 203, 1188-94. (1994)
29. Engel, K., H. Schultz, F. Martin, A. Kotlyarov, K. Plath, M. Hahn, U. Heinemann & M. Gaestel: Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem, 270, 27213-21. (1995)
30. Engel, K., A. Kotlyarov & M. Gaestel: Leptomycin Bsensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. Embo J, 17, 3363-71 (1998) (Pubitemid 28279510)
31. Ben-Levy, R., S. Hooper, R. Wilson, H. F. Paterson & C. J. Marshall: Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol, 8, 1049-57 (1998) (Pubitemid 28451029)
32. Meng, W., L. L. Swenson, M. J. Fitzgibbon, K. Hayakawa, E. Ter Haar, A. E. Behrens, J. R. Fulghum & J. A. Lippke: Structure of mitogen-activated protein kinaseactivated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export. J Biol Chem, 277, 37401-5. (2002)
33. Underwood, K. W., K. D. Parris, E. Federico, L. Mosyak, R. M. Czerwinski, T. Shane, M. Taylor, K. Svenson, Y. Liu, C. L. Hsiao, S. Wolfrom, M. Maguire, K. Malakian, J. B. Telliez, L. L. Lin, R. W. Kriz, J. Seehra, W. S. Somers & M. L. Stahl: Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. Structure, 11, 627-36 (2003) (Pubitemid 37281179)
34. Wu, J. P., J. Wang, A. Abeywardane, D. Andersen, M. Emmanuel, E. Gautschi, D. R. Goldberg, M. A. Kashem, S. Lukas, W. Mao, L. Martin, T. Morwick, N. Moss, C. Pargellis, U. R. Patel, L. Patnaude, G. W. Peet, D. Skow, R. J. Snow, Y. Ward, B. Werneburg & A. White: The discovery of carboline analogs as potent MAPKAP-K2 inhibitors. Bioorg Med Chem Lett, 17, 4664-9 (2007) (Pubitemid 47058930)
35. Anderson, D. R., M. J. Meyers, W. F. Vernier, M. W. Mahoney, R. G. Kurumbail, N. Caspers, G. I. Poda, J. F. Schindler, D. B. Reitz & R. J. Mourey: Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2). J Med Chem., 50, 2647-54. Epub 2007 May 5. (2007)
36. Clifton, A. D., P. R. Young & P. Cohen: A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett, 392, 209-14 (1996) (Pubitemid 26289115)
37. Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein & A. R. Nebreda: Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell, 6, 109-16 (2000)
38. Ben-Levy, R., I. A. Leighton, Y. N. Doza, P. Attwood, N. Morrice, C. J. Marshall & P. Cohen: Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. Embo J, 14, 5920-30. (1995)
39. Lukas, S. M., R. R. Kroe, J. Wildeson, G. W. Peet, L. Frego, W. Davidson, R. H. Ingraham, C. A. Pargellis, M. E. Labadia & B. G. Werneburg: Catalysis and function of the p38 alpha.MK2a signaling complex. Biochemistry, 43, 9950-60 (2004) (Pubitemid 39030885)
40. Kotlyarov, A., Y. Yannoni, S. Fritz, K. Laass, J. B. Telliez, D. Pitman, L. L. Lin & M. Gaestel: Distinct cellular functions of MK2. Mol Cell Biol, 22, 4827-35. (2002) (Pubitemid 34620417)
41. Sudo, T., K. Kawai, H. Matsuzaki & H. Osada: p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. Biochem Biophys Res Commun, 337, 415-21 (2005) (Pubitemid 41429300)
42. Zhang, W. X., R. Wang, D. Wisniewski, A. I. Marcy, P. LoGrasso, J. M. Lisnock, R. T. Cummings & J. E. Thompson: Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase. Anal Biochem, 343, 76-83 (2005) (Pubitemid 40978611)
43. ter Haar, E., P. Prabhakar, X. Liu & C. Lepre: Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer. J Biol Chem, 282, 9733-9 (2007) (Pubitemid 47104583)
44. White, A., C. A. Pargellis, J. M. Studts, B. G. Werneburg & B. T. Farmer, 2nd: Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc Natl Acad Sci U S A, 104, 6353-8 (2007) (Pubitemid 47186098)
45. Yannoni, Y. M., M. Gaestel & L. L. Lin: P66 (ShcA) interacts with MAPKAP kinase 2 and regulates its activity. FEBS Lett, 564, 205-11 (2004) (Pubitemid 38490725)
46. Voncken, J. W., H. Niessen, B. Neufeld, U. Rennefahrt, V. Dahlmans, N. Kubben, B. Holzer, S. Ludwig & U. R. Rapp: MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J Biol Chem, 280, 5178-87 (2005) (Pubitemid 40279988)
47. Zaru, R., N. Ronkina, M. Gaestel, J. S. Arthur & C. Watts: The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat Immunol, 8, 1227-35 (2007) (Pubitemid 350011762)
48. Guay, J., H. Lambert, G. Gingras-Breton, J. N. Lavoie, J. Huot & J. Landry: Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci, 110, 357-68. (1997) (Pubitemid 27095655)
49. Hannigan, M. O., L. Zhan, Y. Ai, A. Kotlyarov, M. Gaestel & C. K. Huang: Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 2-/-neutrophils in Zigmond chambers containing formylmethionyl-leucyl-phenylalanine gradients. J Immunol, 167, 3953-61 (2001)
50. Wu, Y., M. O. Hannigan, A. Kotlyarov, M. Gaestel, D. Wu & C. K. Huang: A requirement of MAPKAPK2 in the uropod localization of PTEN during FMLP-induced neutrophil chemotaxis. Biochem Biophys Res Commun, 316, 666-72 (2004) (Pubitemid 38368004)
51. Rousseau, S., I. Dolado, V. Beardmore, N. Shpiro, R. Marquez, A. R. Nebreda, J. S. Arthur, L. M. Case, M. Tessier-Lavigne, M. Gaestel, A. Cuenda & P. Cohen: CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal, 18, 1897-905 (2006) (Pubitemid 44485980)
52. Manke, I. A., A. Nguyen, D. Lim, M. Q. Stewart, A. E. Elia & M. B. Yaffe: MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell., 17, 37-48. (2005) (Pubitemid 40075363)
53. Clifton, A. D., P. R. Young & P. Cohen: A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett, 392, 209-14. (1996) (Pubitemid 26289115)
54. Kotlyarov, A., Y. Yannoni, S. Fritz, K. Laass, J. B. Telliez, D. Pitman, L. L. Lin & M. Gaestel: Distinct cellular functions of MK2. Mol Cell Biol, 22, 4827-35 (2002) (Pubitemid 34620417)
55. Rogalla, T., M. Ehrnsperger, X. Preville, A. Kotlyarov, G. Lutsch, C. Ducasse, C. Paul, M. Wieske, A. P. Arrigo, J. Buchner & M. Gaestel: Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem, 274, 18947-56 (1999)
56. Jakob, U., M. Gaestel, K. Engel & J. Buchner: Small heat shock proteins are molecular chaperones. J Biol Chem, 268, 1517-20. (1993) (Pubitemid 23033534)
57. Huang, L., J. N. Min, S. Masters, N. F. Mivechi & D. Moskophidis: Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis, 45, 487-501 (2007) (Pubitemid 47584207)
58. Lehner, M. D., F. Schwoebel, A. Kotlyarov, M. Leist, M. Gaestel & T. Hartung: Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection. J Immunol, 168, 4667-73. (2002) (Pubitemid 34441374)
59. Neininger, A., D. Kontoyiannis, A. Kotlyarov, R. Winzen, R. Eckert, H. D. Volk, H. Holtmann, G. Kollias & M. Gaestel: MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem, 277, 3065-8. (2002) (Pubitemid 34953164)
60. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch & H. Holtmann: The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinaseactivated protein kinase 2 and an AU-rich region-targeted mechanism. Embo J, 18, 4969-80 (1999) (Pubitemid 29443799)
61. Bollig, F., R. Winzen, M. Gaestel, S. Kostka, K. Resch & H. Holtmann: Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem Biophys Res Commun, 301, 665-70. (2003) (Pubitemid 36268942)
62. Rousseau, S., N. Morrice, M. Peggie, D. G. Campbell, M. Gaestel & P. Cohen: Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. Embo J, 21, 6505-14. (2002) (Pubitemid 35448428)
63. Chrestensen, C. A., M. J. Schroeder, J. Shabanowitz, D. F. Hunt, J. W. Pelo, M. T. Worthington & T. W. Sturgill: MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem, 279, 10176-84. Epub 2003 Dec 19. (2004)
64. Stoecklin, G., T. Stubbs, N. Kedersha, S. Wax, W. F. Rigby, T. K. Blackwell & P. Anderson: MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. Embo J, 23, 1313-24. Epub 2004 Mar 11. (2004)
65. Tran, H., F. Maurer & Y. Nagamine: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol, 23, 7177-88 (2003) (Pubitemid 37211000)
66. Chen, C. Y., R. Gherzi, S. E. Ong, E. L. Chan, R. Raijmakers, G. J. Pruijn, G. Stoecklin, C. Moroni, M. Mann & M. Karin: AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell, 107, 451-64 (2001) (Pubitemid 33152781)
67. Deleault, K. M., S. J. Skinner & S. A. Brooks: Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol, 45, 13-24 (2008) (Pubitemid 47331659)
68. Brook, M., C. R. Tchen, T. Santalucia, J. McIlrath, J. S. Arthur, J. Saklatvala & A. R. Clark: Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol, 26, 2408-18 (2006) (Pubitemid 43346939)
69. Hitti, E., T. Iakovleva, M. Brook, S. Deppenmeier, A. D. Gruber, D. Radzioch, A. R. Clark, P. J. Blackshear, A. Kotlyarov & M. Gaestel: Mitogen-activated protein kinaseactivated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol, 26, 2399-407 (2006) (Pubitemid 43346938)
70. Mendoza, H., D. G. Campbell, K. Burness, J. Hastie, N. Ronkina, J. H. Shim, J. S. Arthur, R. J. Davis, M. Gaestel, G. L. Johnson, S. Ghosh & P. Cohen: Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem J, 409, 711-22 (2008) (Pubitemid 351214197)
71. Ishitani, T., G. Takaesu, J. Ninomiya-Tsuji, H. Shibuya, R. B. Gaynor & K. Matsumoto: Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. Embo J, 22, 6277-88 (2003) (Pubitemid 37522585)
72. Kanayama, A., R. B. Seth, L. Sun, C. K. Ea, M. Hong, A. Shaito, Y. H. Chiu, L. Deng & Z. J. Chen: TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell, 15, 535-48 (2004) (Pubitemid 39141781)
73. Lee, J. C., S. Kumar, D. E. Griswold, D. C. Underwood, B. J. Votta & J. L. Adams: Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology, 47, 185-201 (2000) (Pubitemid 30394538)
74. Wang, Y., R. Singh, J. H. Lefkowitch, R. M. Rigoli & M. J. Czaja: Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem, 281, 15258-67 (2006) (Pubitemid 43855115)
75. Galanos, C., M. A. Freudenberg & W. Reutter: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A, 76, 5939-43 (1979) (Pubitemid 10216692)
76. Hegen, M., M. Gaestel, C. L. Nickerson-Nutter, L. L. Lin & J. B. Telliez: MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol, 177, 1913-7 (2006) (Pubitemid 44092531)
77. Jagavelu, K., U. J. Tietge, M. Gaestel, H. Drexler, B. Schieffer & U. Bavendiek: Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice. Circ Res, 101, 1104-12 (2007) (Pubitemid 350146436)
78. Gorska, M. M., Q. Liang, S. J. Stafford, N. Goplen, N. Dharajiya, L. Guo, S. Sur, M. Gaestel & R. Alam: MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation. J Exp Med, 204, 1637-52 (2007) (Pubitemid 47048030)
79. Liu, T., R. R. Warburton, O. E. Guevara, N. S. Hill, B. L. Fanburg, M. Gaestel & U. S. Kayyali: Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis. Am J Respir Cell Mol Biol, 37, 507-17 (2007) (Pubitemid 350058181)
80. Sousa, A. M., T. Liu, O. Guevara, J. Stevens, B. L. Fanburg, M. Gaestel, D. Toksoz & U. S. Kayyali: Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. J Cell Biochem, 100, 1581-92 (2007) (Pubitemid 46515589)
81. Park, J. K., N. Ronkina, A. Hoft, C. Prohl, J. Menne, M. Gaestel, H. Haller & M. Meier: Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy. Nephrol Dial Transplant (2008)
82. Dunlop, M. E. & E. E. Muggli: Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int, 57, 464-75 (2000) (Pubitemid 30430638)
83. Shiroto, K., H. Otani, F. Yamamoto, C. K. Huang, N. Maulik & D. K. Das: MK2-/-gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury. J Mol Cell Cardiol, 38, 93-7 (2005) (Pubitemid 40038655)
84. Nagy, N., K. Shiroto, G. Malik, C. K. Huang, M. Gaestel, M. Abdellatif, A. Tosaki, N. Maulik & D. K. Das: Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target. J Mol Cell Cardiol, 42, 981-90 (2007) (Pubitemid 46678032)
85. Wang, X., L. Xu, H. Wang, P. R. Young, M. Gaestel & G. Z. Feuerstein: Mitogen-activated protein kinaseactivated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J Biol Chem, 277, 43968-72 (2002) (Pubitemid 36157821)
86. Culbert, A. A., S. D. Skaper, D. R. Howlett, N. A. Evans, L. Facci, P. E. Soden, Z. M. Seymour, F. Guillot, M. Gaestel & J. C. Richardson: MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem, 281, 23658-67 (2006) (Pubitemid 44274141)
87. Weber, H. O., R. L. Ludwig, D. Morrison, A. Kotlyarov, M. Gaestel & K. H. Vousden: HDM2 phosphorylation by MAPKAP kinase 2. Oncogene, 24, 1965-72. (2005) (Pubitemid 40516191)
88. Bulavin, D. V., Y. Higashimoto, I. J. Popoff, W. A. Gaarde, V. Basrur, O. Potapova, E. Appella & A. J. Fornace, Jr.: Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature, 411, 102-7 2001 (Pubitemid 32428198)
89. Reinhardt, H. C., A. S. Aslanian, J. A. Lees & M. B. Yaffe: p53-deficient cells rely on ATM-and ATRmediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell, 11, 175-89 (2007) (Pubitemid 46209849)
90. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter & et al.: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-46. (1994)
91. Gaestel, M., A. Mengel, U. Bothe & K. Asadullah: Protein kinases as small molecule inhibitor targets in inflammation. Curr Med Chem, 14, 2214-34 (2007) (Pubitemid 47570683)
92. Dominguez, C., D. A. Powers & N. Tamayo: p38 MAP kinase inhibitors: many are made, but few are chosen. Curr Opin Drug Discov Devel, 8, 421-30 (2005) (Pubitemid 40921741)
93. Allen, M., L. Svensson, M. Roach, J. Hambor, J. McNeish & C. A. Gabel: Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzymedeficient embryonic stem cells. J Exp Med, 191, 859-70. (2000)
94. Zu, Y. L., Y. Ai & C. K. Huang: Characterization of an autoinhibitory domain in human mitogen-activated protein kinase-activated protein kinase 2. J Biol Chem, 270, 202-6. (1995)
95. Anderson, D. R., S. Hegde, E. Reinhard, L. Gomez, W. F. Vernier, L. Lee, S. Liu, A. Sambandam, P. A. Snider & L. Masih: Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett, 15, 1587-90 (2005) (Pubitemid 40312534)